Home › Companies › AURINIA PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and AURINIA PHARMACEUTICALS INC.’s Form 8-K, filed 2024-06-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AURINIA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are AURINIA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Dr. Daniel Billen | 33,343,245 | -- | -- | 43,247,441 | 19,865,665 | Plurality election |
| Elect Director: Mr. Peter Greenleaf | 36,942,214 | -- | -- | 39,681,657 | 19,832,480 | Plurality election |
| Elect Director: Dr. David R.W. Jayne | 47,961,382 | -- | -- | 28,672,488 | 19,822,481 | Majority: yes |
| Elect Director: Mr. R. Hector MacKay-Dunn | 35,001,819 | -- | -- | 41,588,866 | 19,865,666 | Plurality election |
| Elect Director: Ms. Jill Leversage | 48,882,668 | -- | -- | 27,741,202 | 19,832,481 | Majority: yes |
| Elect Director: Dr. Brinda Balakrishnan | 36,406,544 | -- | -- | 40,184,139 | 19,865,668 | Plurality election |
| Elect Director: Dr. Karen Smith | 38,979,544 | -- | -- | 37,644,485 | 19,832,322 | Majority: yes |
| Elect Director: Mr. Jeffrey A. Bailey | 38,651,711 | -- | -- | 37,972,319 | 19,832,321 | Majority: yes |
| Elect Director: Dr. Robert T. Foster | 39,405,046 | -- | -- | 37,218,984 | 19,832,321 | Majority: yes |
| Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of sharehol | 85,574,567 | 8,080,642 | 2,801,141 | -- | 1 | Majority: yes |
| Proposal 3: Based upon the following votes, the shareholders did not approve on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation. | 30,780,033 | 45,321,684 | 522,314 | -- | 19,832,320 | Majority: no |
| Proposal 4: Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan. | 35,700,702 | 40,481,025 | 442,301 | -- | 19,832,323 | Majority: no |
Source: AURINIA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-06-14 — read the filing on EDGAR.
Each item below shows how the 170 asset managers that disclosed a AURINIA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AURINIA PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 14 wordings of this item as funds reported it.
40% Majority: no · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders did not approve on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”): 30,780,033 for, 45,321,684 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 21% for, 32% against (53.0% of the company cast a for/against vote).
The 166 asset managers below cast 80% of the shares they voted on this item FOR (28,432,002 for, 7,255,391 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7,209,884 | 0 | 0 | 0 | For |
| BlackRock | 5,341,492 | 92,814 | 0 | 0 | For |
| NEA Management Company, LLC | 3,969,834 | 0 | 0 | 0 | For |
| Nuveen | 2,041,437 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,653,299 | 0 | 0 | 0 | For |
| State Street | 1,581,955 | 38,935 | 0 | 0 | For |
| Vanguard | 1,539,900 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,184,508 | 0 | 0 | Against |
| Rock Springs Capital Management LP | 975,975 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 906,741 | 0 | 0 | Against |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 734,122 | 0 | 0 | Against |
| 683 Capital Management, LLC | 0 | 585,000 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 557,765 | 0 | 0 | Against |
| Woodline Partners LP | 467,424 | 0 | 0 | 0 | For |
| Equitable | 210,611 | 132,100 | 0 | 0 | For |
| Fidelity | 254,654 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 0 | 247,052 | 0 | 0 | Against |
| Invesco | 0 | 218,782 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 215,833 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 0 | 204,404 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 183,592 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 62,991 | 0 | 0 | For |
| Nationwide | 119,857 | 34,945 | 0 | 0 | For |
Showing the 25 largest of 166 asset managers. See all 166 in the interactive database.
Combines 5 wordings of this item as funds reported it.
44% Plurality election · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Daniel Billen”): 33,343,245 for, 43,247,441 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 143,690,000 outstanding shares: 23% for, 30% withheld (53.3% of the company cast a for/withheld vote).
The 38 asset managers below cast 100% of the shares they voted on this item FOR (8,592,072 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 210,611 | 0 | 132,100 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 0 | 62,991 | 0 | For |
| Nationwide | 121,153 | 0 | 33,649 | 0 | For |
| Invesco | 0 | 0 | 81,129 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 80,000 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 70,525 | 0 | Abstain |
| Northern Trust | 0 | 0 | 62,632 | 0 | Abstain |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,057 | 0 | 34,509 | 0 | Abstain |
| John Hancock | 0 | 0 | 47,939 | 0 | Abstain |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 42,195 | 0 | Abstain |
| ProShares | 0 | 0 | 33,732 | 0 | Abstain |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 19,755 | 0 | Abstain |
| Legg Mason | 0 | 0 | 18,794 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 16,366 | 0 | Abstain |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Combines 5 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm unti”): 85,574,567 for, 8,080,642 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 60% for, 6% against (65% of the company cast a for/against vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,319,688 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 80,000 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 4 wordings of this item as funds reported it.
47.5% Plurality election · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Brinda Balakrishnan”): 36,406,544 for, 40,184,139 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 143,690,000 outstanding shares: 25% for, 28% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (8,858,458 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 0 | 62,991 | 0 | For |
| Nationwide | 121,153 | 0 | 33,649 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,057 | 0 | 34,509 | 0 | Abstain |
| John Hancock | 0 | 0 | 47,939 | 0 | Abstain |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 42,195 | 0 | Abstain |
| ProShares | 0 | 0 | 33,732 | 0 | Abstain |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 19,755 | 0 | Abstain |
| Legg Mason | 0 | 0 | 18,794 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 16,366 | 0 | Abstain |
| Principal | 0 | 0 | 15,837 | 0 | Abstain |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 4 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. David R.W. Jayne”): 47,961,382 for, 28,672,488 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 33% for, 20% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,227,630 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
50.4% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Jeffrey A. Bailey”): 38,651,711 for, 37,972,319 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 27% for, 26% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,241,084 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
64% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ms. Jill Leversage”): 48,882,668 for, 27,741,202 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 34% for, 19% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,227,630 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 4 wordings of this item as funds reported it.
50.9% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Karen Smith”): 38,979,544 for, 37,644,485 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 27% for, 26% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,241,084 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
48.2% Plurality election · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Peter Greenleaf”): 36,942,214 for, 39,681,657 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 143,690,000 outstanding shares: 26% for, 28% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,241,084 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
45.7% Plurality election · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. R. Hector MacKay-Dunn”): 35,001,819 for, 41,588,866 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 143,690,000 outstanding shares: 24% for, 29% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (8,795,826 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 0 | 62,991 | 0 | For |
| Nationwide | 121,153 | 0 | 33,649 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 62,632 | 0 | Abstain |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,057 | 0 | 34,509 | 0 | Abstain |
| John Hancock | 0 | 0 | 47,939 | 0 | Abstain |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 42,195 | 0 | Abstain |
| ProShares | 0 | 0 | 33,732 | 0 | Abstain |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 19,755 | 0 | Abstain |
| Legg Mason | 0 | 0 | 18,794 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 16,366 | 0 | Abstain |
| Principal | 0 | 0 | 15,837 | 0 | Abstain |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 4 wordings of this item as funds reported it.
51.4% Majority: yes · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Robert T. Foster”): 39,405,046 for, 37,218,984 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 27% for, 26% withheld (53.3% of the company cast a for/withheld vote).
The 37 asset managers below cast 100% of the shares they voted on this item FOR (9,241,084 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
46.9% Majority: no · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan.”): 35,700,702 for, 40,481,025 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 25% for, 28% against (53.0% of the company cast a for/against vote).
The 29 asset managers below cast 99.8% of the shares they voted on this item FOR (8,432,730 for, 13,454 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 153,506 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 13,973 | 0 | 0 | 0 | For |
| Calvert | 0 | 13,454 | 0 | 0 | Against |
| ALPS ETF Trust | 11,704 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,773 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 4,871 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Combines 4 wordings of this item as funds reported it.
46.9% Majority: no · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan.”): 35,700,702 for, 40,481,025 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 25% for, 28% against (53.0% of the company cast a for/against vote).
The 7 asset managers below cast 100% of the shares they voted on this item FOR (761,020 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 80,000 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| Nationwide | 1,296 | 0 | 0 | 0 | For |
| Rempart Asset Management Inc. | 650 | 0 | 0 | 0 | For |
| Federated Hermes | 1 | 0 | 0 | 0 | For |
40% Majority: no · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders did not approve on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”): 30,780,033 for, 45,321,684 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 21% for, 32% against (53.0% of the company cast a for/against vote).
The 5 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 436,178 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 379,700 | 0 | 0 | Against |
| ALGERT GLOBAL LLC | 0 | 42,136 | 0 | 0 | Against |
| JPMorgan | 0 | 10,111 | 0 | 0 | Against |
| TD ASSET MANAGEMENT INC | 0 | 2,835 | 0 | 0 | Against |
| CORNELL UNIVERSITY | 0 | 1,396 | 0 | 0 | Against |
46.9% Majority: no · of votes cast
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan.”): 35,700,702 for, 40,481,025 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 143,690,000 outstanding shares: 25% for, 28% against (53.0% of the company cast a for/against vote).
The 3 asset managers below cast 69% of the shares they voted on this item FOR (78,625 for, 34,509 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Bridge Builder Trust | 25,057 | 34,509 | 0 | 0 | Against |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| JPMorgan | 5,629 | 0 | 0 | 0 | For |
Ranked by the number of AURINIA PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 143,690,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 5.02% |
| 2 | BlackRock | 3.78% |
| 3 | NEA Management Company, LLC | 2.76% |
| 4 | Nuveen | 1.42% |
| 5 | TIAA | 1.42% |
| 6 | Goldman Sachs | 1.15% |
| 7 | State Street | 1.13% |
| 8 | Vanguard | 1.07% |
| 9 | Charles Schwab | 0.82% |
| 10 | Rock Springs Capital Management LP | 0.68% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 5.18% | 13F |
| State Street | 1.93% | 13F |
| Nuveen | 1.43% | 13F |
| Morgan Stanley | 1.35% | 13F |
| Geode Capital | 1.12% | 13F |
| Vanguard Group | 1.08% | 13F |
| Northern Trust | 0.71% | 13F |
| Goldman Sachs | 0.59% | 13F |
| Citadel Advisors | 0.51% | 13F |
| Charles Schwab | 0.38% | 13F |
Percentages above are of 143,690,000 shares outstanding, as reported by AURINIA PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AURINIA PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AURINIA PHARMACEUTICALS INC.'s shareholder meeting held 2024-06-14, in the 2023-2024 proxy season, 170 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,402 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a… — FOR was 40% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AURINIA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-14.
AURINIA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.